Live cell imaging is the study of living cells using time-lapse microscopy. This technique has revolutionized cell biology by facilitating cell structure and process observation in real time, and over time leading to better insight into the operations of a cell. Imaging live cells involves a range of contrast-enhanced imaging methods for optical microscopy. An increasing number of investigations are using live cell imaging to provide critical insight into the fundamental nature of cellular and tissue function. Live cell imaging is an important analytical tool used in laboratories to study biomedical research disciplines, such as neurobiology, pharmacology, cell biology, and developmental biology.

Market Dynamics:

Increasing prevalence of chronic diseases, investment/funding for research in live-cell imaging, growing geriatric population, increasing adoption of high-content screening techniques in drug discovery, and increasing development of innovative products are some major factors expected to aid in the growth of the global live cell imaging market over the forecast period.

The increasing prevalence of chronic diseases has increased the demand for diagnostic facilities for a fast and reliable diagnosis, and live cell imaging techniques are among those diagnostic techniques, thus driving the growth of the market. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death worldwide, taking an estimated 17.9 million lives each year, representing 32% of all global deaths.

Key features of the study:

• This report provides in-depth analysis of the global live cell imaging market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global live cell imaging market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KgaA, PerkinElmer Inc., Live Cell Instrument, Olympus Corporation, Danaher Corporation, CytoSMART Technologies, ZEISS Group, Nikon Instruments Inc., and Becton, Dickinson and Company, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global live cell imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global live cell imaging market.

Detailed Segmentation:

• Global Live Cell Imaging Market, By Product:
  • Equipment
  • Consumables
  • Software and Services
• Global Live Cell Imaging Market, By Application:
  • Cell Biology
  • Developmental Biology
  • Stem Cell Biology
  • Drug Discovery
  • Other Applications
• Global Live Cell Imaging Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
  • Thermo Fisher Scientific Inc.
  • Merck KgaA
  • PerkinElmer Inc.
  • Nikon Instruments Inc.
  • Live Cell Instrument
  • Olympus Corporation
  • Danaher Corporation
  • CytoSMART Technologies
  • ZEISS Group
  • Becton, Dickinson and Company